"10.1371_journal.pmed.0040133","plos medicine","2007-04-17T00:00:00Z","Friedemann Paul; Sven Jarius; Orhan Aktas; Martin Bluthner; Oliver Bauer; Heribert Appelhans; Diego Franciotta; Roberto Bergamaschi; Edward Littleton; Jacqueline Palace; Hans-Peter Seelig; Reinhard Hohlfeld; Angela Vincent; Frauke Zipp","Cecilie-Vogt-Clinic for Molecular Neurology, Charit√©, University Medicine Berlin, Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; Institute of Clinical Neuroimmunology, University of Munich, Munich, Germany; Department of Clinical Neurology, University of Oxford, Oxford, United Kingdom; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; Institute of Immunology and Molecular Genetics, Karlsruhe, Germany; Istituto di Ricovero e Cura a Carattere Scientifico, Foundation Neurological Institute C. Mondino, University of Pavia, Pavia, Italy","FP, SJ, OA, and FZ designed the study. FP, SJ, OA, MB, and OB analyzed the data. FP, SJ, OA, RB, EL, JP, RH, and FZ enrolled patients. FP, SJ, OA, MB, DF, RH, AV, and FZ contributed to writing the paper. FP, OA, OB, DF, RB, HPS, RH, and FZ collected data or performed experiments for the study. FP, SJ, DF, RB, EL, JP, RH, and FZ collected and analyzed clinical, CSF, and MRI data, and tested patient sera. HA performed all experiments concerning the molecular cloning of aquaporin cDNA, verifying the DNA sequence, and choosing and providing the expression plasmid for in vitro transcription/translation. AV suggested additional experiments that were done before submission.","The authors have declared that no competing interests exist.","2007","04","Friedemann Paul","FP",14,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
